Search Results - "Zaritskey, A"

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia by Hochhaus, A., Baccarani, M., Silver, R. T., Schiffer, C., Apperley, J. F., Cervantes, F., Clark, R. E., Cortes, J. E., Deininger, M. W., Guilhot, F., Hjorth-Hansen, H., Hughes, T. P., Janssen, J. J. W. M., Kantarjian, H. M., Kim, D. W., Larson, R. A., Lipton, J. H., Mahon, F. X., Mayer, J., Nicolini, F., Niederwieser, D., Pane, F., Radich, J. P., Rea, D., Richter, J., Rosti, G., Rousselot, P., Saglio, G., Saußele, S., Soverini, S., Steegmann, J. L., Turkina, A., Zaritskey, A., Hehlmann, R.

“…The therapeutic landscape of chronic myeloid leukemia (CML) has profoundly changed over the past 7 years. Most patients with chronic phase (CP) now have a…”
Get full text

The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries by Hoffmann, V S, Baccarani, M, Hasford, J, Lindoerfer, D, Burgstaller, S, Sertic, D, Costeas, P, Mayer, J, Indrak, K, Everaus, H, Koskenvesa, P, Guilhot, J, Schubert-Fritschle, G, Castagnetti, F, Di Raimondo, F, Lejniece, S, Griskevicius, L, Thielen, N, Sacha, T, Hellmann, A, Turkina, A G, Zaritskey, A, Bogdanovic, A, Sninska, Z, Zupan, I, Steegmann, J-L, Simonsson, B, Clark, R E, Covelli, A, Guidi, G, Hehlmann, R

“…This population-based registry was designed to provide robust and updated information on the characteristics and the epidemiology of chronic myeloid leukemia…”
Get full text

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry by Hoffmann, V S, Baccarani, M, Hasford, J, Castagnetti, F, Di Raimondo, F, Casado, L F, Turkina, A, Zackova, D, Ossenkoppele, G, Zaritskey, A, Höglund, M, Simonsson, B, Indrak, K, Sninska, Z, Sacha, T, Clark, R, Bogdanovic, A, Hellmann, A, Griskevicius, L, Schubert-Fritschle, G, Sertic, D, Guilhot, J, Lejniece, S, Zupan, I, Burgstaller, S, Koskenvesa, P, Everaus, H, Costeas, P, Lindoerfer, D, Rosti, G, Saussele, S, Hochhaus, A, Hehlmann, R

“…The European Treatment and Outcome Study (EUTOS) population-based registry includes data of all adult patients newly diagnosed with Philadelphia…”
Get full text

Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins by Konopleva, M, Konoplev, S, Hu, W, Zaritskey, A Y, Afanasiev, B V, Andreeff, M

“…The aim of this study was to study interactions between stromal bone marrow microenvironment and leukemic cells. We tested the hypothesis that stromal cells…”
Get full text

Ovarian tissue cryopreservation in prepubertal patients with oncological diseases: multidisciplinary approach and outcomes by Dinikina, Yulia, Belogurova, Margarita, Zaritskey, Andrey, Govorov, Igor, Tsibizova, Valentina, Gamzatova, Zaynab, Pervunina, Tatyana, Komlichenko, Eduard

“…In children with cancer, the issues related to the quality of life are becoming increasingly important together with the improvement of survival rates. This…”
Get full text

CASC5 Gene Expression Changes Correlate with Targeted Mutations in Leukemia by Bogdanov, K. V., Merzlikina, O. V., Mirolyubova, Y. V., Girshova, L. L., Lomaia, E. G., Zaritskey, A. Y.

“…Dysfunction of genes that control mitosis and are responsible for the correct segregation of sister chromatids in anaphase is often accompanied by aneuploidy,…”
Get full text

P49 by Silyutina, A, Zhuk, S, Butylin, P, Zaritskey, A

“…Background Myelofibrosis with myeloid metaplasia is chronic mieloproliferative disease with ineffective erythropoiesis, dysplastic-megakaryocyte hyperplasia,…”
Get full text

Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases by Melikyan, A L, Subortseva, I N, Gilyazitdinova, E A, Koloshejnova, T I, Pustovaya, E I, Egorova, E K, Kovrigina, A M, Sudarikov, A B, Abdullaev, A O, Lomaia, E G, Siordiya, N T, Zaritskey, A Yu, Savchenko, V G

“…A comparative evaluation of the effectiveness of different therapeutic strategies in patients with polycythemia vera (PV) and essential thrombocythemia (ET)…”
Get full text

Identification of oncogene mutations in leukemia patients using microchip-based PCR analysis by Bogdanov, K. V., Nikulina, T. S., Lomaia, E. G., Slyadnev, M. N., Zaritskey, A. Y.

“…At present, cytogenetic and PCR-based techniques are generally used in the diagnosis of leukemia. Due to high accuracy, specificity, and sensitivity of PCR…”
Get full text

5.34 Efficacy of FC and FCR Regimens in the First-Line Treatment of Patients with Chronic Lymphocytic Leukemia: 9 Years of Follow-up by Stadnik, E, Zaritskey, A

Get full text

Markers of the basal cell layer of prostate are effective indicators of its malignant transformation by Petrov, N. S., Voskresenskiy, M. A., Grozov, R. V., Korshak, O. V., Zaritskey, A. Y., Vereschagina, N. A., Komyakov, B. K., Popov, B. V.

“…Development of local or generalized forms of prostate cancer (PC) depends on metastasis formation which biological nature is based on the epithelial…”
Get full text

EFFECTIVENESS OF VENETOСLAX IN THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (LITERATURE REVIEW) by Strugov, V. V., Stadnik, E. A., Zaritskey, A. Yu

“…Currently we are facing a revolution in therapy of chronic lymphocytic leukemia, related to the development of novel target drugs, which have markedly improved…”
Get full text

T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC) by Olsnes, Astrid Marta, Motorin, Dmitri, Ryningen, Anita, Zaritskey, Andrey Y, Bruserud, Øystein

“…T cell targeting immunotherapy is now considered in acute myelogenous leukemia (AML), and local recruitment of antileukemic T cells to the AML microcompartment…”
Get full text

Children and adults with acute lymphoblastic leukaemia have similar gene expression profiles by Kuchinskaya, E., Heyman, M., Grandér, D., Linderholm, M., Söderhäll, S., Zaritskey, A., Nordgren, A., Porwit-MacDonald, A., Zueva, E., Pawitan, Y., Corcoran, M., Nordenskjöld, M., Blennow, E.

“…:  Objectives: To compare the gene expression pattern in children and adults with acute lymphoblastic leukaemia (ALL) in order to improve our understanding of…”
Get full text

P694Evaluation of preclinical atherosclerosis in chronic myeloid patients continuously treated with tyrosine kinase inhibitors by Shnalieva, N, Zammoeva, D, Chitanava, T, Chiritso, M, Boiarinova, M, Vasilieva, E, Lomaia, E, Zaritskey, A

“…Abstract In tyrosine kinase inhibitors (TKIs) era chronic myeloid leukemia (CML) became from fatal to well controlled chronic disease. Meanwhile it seems that…”
Get full text

Analysis of the progression-free survival of CLL patients who received first-line bendamustine-rituximab therapy depending on the elimination rate of the minimum residual disease and mutational status IGHV genes by Miroliubova, I., Stadnik, E., Strugov, V., Virz, Y., Nikulina, T., Tolstopiatova, E., Rumyantsev, A., Chatalava, T., Timofeeva, N., Zaritskey, A.

Get full text

OP-15 - Analysis of the progression-free survival of CLL patients who received first-line bendamustine-rituximab therapy depending on the elimination rate of the minimum residual disease and mutational status IGHV genes by Miroliubova, I., Stadnik, E., Strugov, V., Virz, Y., Nikulina, T., Tolstopiatova, E., Rumyantsev, A., Chatalava, T., Timofeeva, N., Zaritskey, A.

Get full text

Gemtuzumab ozogamicin in the treatment of critically ill patients with refractory acute myeloid leukemia by Zaytsev, D., Girshova, L., Ivanov, V., Budaeva, I., Motorin, D., Badaev, R., Bogdanov, K., Mirolubova, J., Nikulina, T., Chitanava, T., Alexeeva, J., Zaritskey, A.

Get full text

Aza maintenance after consolidation increase RFS in MRDve+ low and not in intermediate risk AML patients by Girshova, L., Budaeva, I., Zaytsev, D., Chitanava, T., Rogovaia, I., Badaev, R., Bogdanov, K., Nikulina, T., Mirolubova, J., Motorin, D., Alexeeva, J., Zaritskey, A.

Get full text

PP-71 - Gemtuzumab ozogamicin in the treatment of critically ill patients with refractory acute myeloid leukemia by Zaytsev, D., Girshova, L., Ivanov, V., Budaeva, I., Motorin, D., Badaev, R., Bogdanov, K., Mirolubova, J., Nikulina, T., Chitanava, T., Alexeeva, J., Zaritskey, A.

Get full text